Market Briefing. Belgium. 28th January
Upcoming SlideShare
Loading in...5

Market Briefing. Belgium. 28th January






Total Views
Views on SlideShare
Embed Views



0 Embeds 0

No embeds



Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
Post Comment
Edit your comment

Market Briefing. Belgium. 28th January Market Briefing. Belgium. 28th January Presentation Transcript

  • Opportunities in the Belgian energy sector Gert Wauters Senior Trade & Investment Adviser UKTI Belgium
  • Main points  Why Belgium ?  Belgium and its energy policy  What about nuclear ?  Opportunities in nuclear decommissioning  Key organisations
  • Why Belgium ?
  • Why Belgium ?  Belgium is the UK’s sixth-largest export market, worth £10 billion a year. The UK is Belgium’s fourth-largest export market with two-way trade worth in the region of £22 billion.  Ideal test market but competitive market place  Interesting mix of Belgian companies, decision centres and EHQ’s
  • Energy policy in Belgium
  • Energy policy in Belgium Federal level Nuclear Offshore renewables Security of supply Large storage infrastructure Energy production and transmission
  • Energy policy in Belgium Federal level Regional level Nuclear Energy efficiency Offshore renewables Onshore renewables Security of supply Non-nuclear energy R&D Large storage infrastructure Energy from waste Energy production and transmission Distribution grid
  • Energy policy in Belgium  Nuclear : - substantial share in electricity generation → nevertheless decision in 2012 to phase out nuclear as of 2015  Incentives for combined cycle gas turbine (CCGT) plants  Renewables : target = 13% of energy generated by 2020  Early mover for offshore wind projects (2007)
  • What about nuclear ? Generating capacity Renewable 11% Hydro 7% Renewable 21% Fossil fuel (gas) 43% Data : 2011 Electricity generated Nuclear 29% Fossil fuel (gas) 34% Hydro 2% Nuclear 53%
  • Nuclear sites in Belgium Doel : Doel Mol - Dessel -4 PW Reactors - operational 1974 Tihange : Tihange Fleurus -3 PW Reactors -Operational 1975 Both sites owned and operated by Electrabel (part of GDF Suez)
  • Nuclear sites in Belgium Mol – Dessel : Doel Mol - Dessel - Nuclear fuel production site (FBFC – part of Areva) -Nuclear disposal facility (Belgoprocess) Tihange Fleurus - Nuclear Research Centre (SCK-CEN) Fleurus : Production of radioElements for use in nuclear Medicine (IRE)
  • Opportunities in nuclear decommissioning  July 2012 : Belgian government decides on nuclear phase out by 2015  Timetable for the phase-out of the seven reactors 2015 Doel 1 Doel 2 2022 Doel 3 2023 Tihange 2 2025 Tihange 1 Tihange 3 Doel 4  First phase of the process (2016-2019) will focus on the spent nuclear fuel. Currently 120 tonnes of highly radioactive spent fuel is produced annually. In Doel it is stored dry in containers, in Tihange a spent fuel pool is used.  No tendering process
  • Key organisations  part of GDF-Suez  former monopoly supply gas & electricity in Belgium  owner & operator of nuclear reactors (Doel & Tihange)  Decommissioning and Dismantling Belgium  Nuclear generation  part of GDF-Suez  decommissioning engineer for Doel 1 & 2  Due Diligence  Procurement  Construction (EPCM/PMC)  Operation  Decommissioning
  • Key organisations  National Agency for Radioactive Waste and Enriched Fissile Materials  Responsible for collecting information (timing, process, cost estimate, risk assessment etc.) related to the decommissioning programmes, approving these programmes, executing the programme at the request of the operator.  Subsidiary of NIRAS  Processing and storage of radioactive wastes  Advice on decontamination, dismantling and waste management
  • Further information Contact E Sectors Energy Engineering T +32 2 287 62 24 Chemicals Pharma Biotech Materials Transport